Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Search results (9)

« Back to Publications

Unified Metric of Human Immune Health?

Baird T. and Sansom SN., (2025), Transplantation, 109, 1269 - 1270

IFNγ Production by Functionally Reprogrammed Tregs Promotes Antitumor Efficacy of OX40/CD137 Bispecific Agonist Therapy.

Imianowski CJ. et al, (2024), Cancer Res Commun, 4, 2045 - 2057

GS-TCGA: Gene Set-Based Analysis of The Cancer Genome Atlas.

Baird T. and Roychoudhuri R., (2024), J Comput Biol, 31, 229 - 240

Identifying employee, workplace and population characteristics associated with COVID-19 outbreaks in the workplace: a population-based study.

Overton CE. et al, (2024), Occup Environ Med, 81, 92 - 100

Understanding the leading indicators of hospital admissions from COVID-19 across successive waves in the UK.

Mellor J. et al, (2023), Epidemiol Infect, 151

Retrospective analysis of Schlafen11 (SLFN11) to predict the outcomes to therapies affecting the DNA damage response.

Willis SE. et al, (2021), Br J Cancer, 125, 1666 - 1676

SLFN11 informs on standard of care and novel treatments in a wide range of cancer models.

Winkler C. et al, (2021), Br J Cancer, 124, 951 - 962

The effect of Council decision making on the ability of Cambridgeshire communities to develop initiatives that lessen the need for formal health and social care services

Fletcher-Etherington A. et al, (2021)

Meeting Abstracts of the BACR conference: response and resistance in cancer therapy Abstracts

(2018), CANCER DRUG RESISTANCE, 1, 266 - 302